Aurora Cannabis Inc.

NASDAQ:ACB

Drug Manufacturers - Specialty & Generic

Healthcare
$4.40 +0.51%

+$0.02 today

Market cap
$289.28M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $2.73High $6.67

Volume 0.92M

Average 1.00M

ACB Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Aurora Cannabis Inc.NASDAQ: ACB

Other Income / Expenses · Q4 FY2026 · quarter ended Mar 2026

Other income / expenses growth accelerates

Q4 FY2026 other income / expenses of CA$36.62M rose 252.1% year over year, ahead of the -137.8% change in trailing-twelve-month other income / expenses.

Context

  • Other income / expenses amounted to 33.1% of revenue in FY2026, up 28.7 pp from a year earlier.
  • Other income / expenses increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +252.1% holds above the trailing-twelve-month pace of -137.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$36.62M+673.5% QoQ
Last fiscal yearMar 2026
CA$106.54M+590.3% YoY
LTMMar 2026
-CA$5.83M-137.8% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+252.1%——
1 year+590.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

CAD · from the income statement

Latest · FY2026
106.54M CAD
Year-over-year change
+590.3%

Other Income / Expenses vs competitors

How ACB compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -137.8% is the 7th highest of 10, against a peer median of -4.6%.
  • Other income / expenses amounts to 1.9% of revenue for ACB, versus a peer median of 12.5%.
ACB Competitors
Other Income / Expenses for ACB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BIOABioAge Labs, Inc.LTM Mar 2026$11.78M USD+9.2%+266.7%114.2%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$10.82M USD-0.5%+57.2%129.3%
EDITEditas Medicine, Inc.LTM Mar 2026$6.16M USD-32.3%—15.9%
TKNOAlpha Teknova, Inc.LTM Mar 2026-$776K USD-286.1%—1.9%
LFMDLifeMD, Inc.LTM Mar 2026-$2M USD+14.1%—0.9%
ACBAurora Cannabis Inc.LTM Mar 2026-CA$5.83M CAD-137.8%—1.9%
OGIOrganigram Global Inc.LTM Mar 2026-CA$24.75M CAD-168.6%—9.0%
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 2026-$30.37M USD-4.6%—8.4%
LFCRLifecore Biomedical, Inc.LTM Mar 2026-$33.6M USD——24.9%
HITIHigh Tide Inc.LTM Apr 2026-CA$42.77M CAD-322.5%—6.4%
CGCCanopy Growth CorporationLTM Mar 2026-CA$182.91M CAD+61.9%—58.6%
Peer median (excluding ACB) —-4.6%+161.9%12.5%

Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M223.8M270.28M343.29M321.42M
Cost of Revenue200.11M209.02M138.82M155.69M304.67M
Gross Profit21.23M14.78M131.46M187.61M16.75M
Gross Margin9.6%6.6%48.6%54.6%5.2%
Research & Development10.39M5.77M3.57M3.68M6.01M
Selling, General & Admin188.99M170.48M156.88M166.47M173.95M
Operating Expenses252.67M221.98M177.91M182.66M179.96M
Depreciation & Amortization93.66M52.59M33.07M22.55M14.23M
EBITDA(1.55B)(135M)(12.34M)51.35M(148.99M)
EBITDA Margin-702.4%-60.3%-4.6%15.0%-46.4%
Operating Income(231.45M)(207.19M)(46.45M)4.95M(163.21M)
Operating Margin-104.6%-92.6%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.86M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(576.51M)(13.15M)15.43M106.54M
Income Before Tax(1.72B)(783.7M)(59.6M)20.38M(56.67M)
Pre-Tax Margin-777.1%-350.2%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)16.55M(554K)4.62M2.1M
Net Income(1.72B)(816.63M)(69.33M)1.59M(122.07M)
Net Margin-776.0%-364.9%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

NASDAQ:ACB

Intrinsic Alpha fair value

Locked

Current Price

$4.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.